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Abstract We examined fusion mediated by the human im-
munodeficiency virus type 1 (HIV-1) and type 2 (HIV-2)
envelope glycoproteins under various experimental conditions.
Incubation of HeLa cells expressing HIV-2ROD and HIV-
2SBL=ISY envelope glycoproteins with HeLa-CD4 target cells
resulted in fusion at temperatures v25‡C whereas fusion with
cells expressing HIV-1Lai occurred only at v31‡C. HIV-2
envelope glycoprotein-mediated fusion proceeded in the absence
of Ca2+ in the culture medium, whereas HIV-1 fusion required
Ca2+ ions for fusion. In contrast to HIV-2 envelope glycoprotein
fusion, incubations in the presence of the 0.5 WM cytochalasin B
completely inhibited HIV-1 envelope glycoprotein-mediated
fusion. Our results suggest that in contrast to HIV-2, HIV-1
fusion is dependent on dynamic processes in the target
membrane.
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1. Introduction
Human immunode¢ciency virus type 1 (HIV-1) and type 2
(HIV-2) enter permissive cells by interaction with the cellular
receptor CD4, and an appropriate chemokine coreceptor fol-
lowed by fusion of viral and target membranes [1]. Despite a
similar genetic organization of HIV-1 and HIV-2, their amino
acid sequences are considerably divergent (see the HIV se-
quence database on http://hiv-web.lanl.gov/). HIV-1 is pri-
marily prevalent in the USA and Europe, whereas HIV-2 is
endemic in West Africa as well as the west coast of India (see
epidemiological data on http://www.who.org/). A number of
distinct di¡erences between HIV-1 and HIV-2 envelope glyco-
proteins in their ability to mediate viral entry have been re-
ported: (a) a broad range of chemokine receptors are used by
HIV-2 as coreceptors with CD4 [2,3], whereas HIV-1 is more
restricted in its host range and utilization of chemokine re-
ceptors, (b) naturally occurring strains of HIV-2 envelope
glycoprotein have been identi¢ed which promote e⁄cient fu-
sion and viral entry in the absence of target cell CD4 [4],
whereas CD4-independent HIV-1 envelope glycoprotein phe-
notypes have only been produced in the laboratory [5], (c) in
contrast to HIV-2, entry mediated by HIV-1 envelope glyco-
protein requires presence of glycosphingolipids in the target
membrane [6].
An examination of di¡erences in fusion phenotype between
two closely related viruses may lead to a better understanding
of the molecular interactions of envelope proteins with the
targets leading to fusion. Therefore, we studied the e¡ects of
temperature, Ca2 and F-actin polymerization on fusion ac-
tivity mediated by HIV-1 and HIV-2 envelope glycoproteins.
We report here that the temperature threshold for HIV-2
envelope glycoprotein-mediated fusion is lower as compared
to that for HIV-1. HIV-2 envelope glycoprotein-mediated fu-
sion does not require the presence of Ca2 in the incubation
medium although fusion is reduced in the absence of Ca2
ions. Moreover, HIV-2 envelope glycoprotein-mediated fusion
is not a¡ected by cytochalasin B, which impairs F-actin poly-
merization in the cytoskeleton. Thus we observe considerable
di¡erences in fusion phenotype between HIV-1 and HIV-2
envelope glycoproteins when physicochemical conditions are
varied.
2. Materials and methods
Fluorescent probes were obtained from Molecular Probes (Eugene,
OR, USA) and tissue culture media were from Gibco BRL (Life Tech,
Gaithersburg, MD, USA). Other reagents were from Sigma Chemical
Company (St. Louis, MO, USA).
2.1. Cells
HeLa cell lines stably expressing human CD4 (HeLa-CD4) and the
parental HeLa cells were a gift from Dr. John Silver. NIH 3T3 cells
stably expressing human CD4 (3T3-CD4) were a gift from Dr. Dan
Litman (Howard Hughes Medical Institute). Cells were grown in
Dulbecco’s modi¢ed Eagle’s medium (DMEM) supplemented with
10% heat-inactivated fetal bovine serum (FBS) (D10).
2.2. Expression of HIV envelope proteins
HIV envelope proteins were transiently expressed on the surface of
HeLa cells using the following recombinant vaccinia constructs:
(i) rVV/ROD (encoding the gene for HIV-2ROD envelope under the
control of the vaccinia P7.5 early/late promoter); (ii) rVV/ST (encod-
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ing HIV-2ST envelope gene under the control of the vaccinia P7.5
early/late promoter) [7]; (iii) vSC50 (expressing HIV-2SBL=ISY enve-
lope, an infectious molecular clone of isolate SBL6669 under the
control of the vaccinia P7.5 promoter) [8]; (iv) vPE16 (expressing
HIV-1Lai (BH8) envelope). The infections were done as described
[9]. Brie£y, 2U106 HeLa cells were plated on a 75 cm2 tissue culture
£ask 6^8 h prior to infection. The virus (10 multiplicity of infection)
was allowed to bind to the cells in 1.5 ml of DMEM containing 2%
FBS for 2 h at 37‡C. The cells were removed from the £asks with mild
trypsinization and resuspended in D10. The infection was continued
further for 14^16 h at 31‡C, at which time the infected cells were
washed and used in a fusion assay as described below.
2.3. HIV envelope glycoprotein-mediated cell^cell fusion
To monitor cell^cell fusion, we used HeLa-CD4 and 3T3-CD4 as
target cells and gp120^gp41-expressing HeLa cells as e¡ectors. The
target cells were plated on 12-well tissue culture plates at 105 cells per
well, and labeled with the cytoplasmic dye (5-(and 6)-(((4-chloro-
methyl)benzoyl)amino)tetramethylrhodamine (CMTMR) (10 WM,
ex/em 550/565 mm) [6]. The HIV envelope glycoprotein-expressing
cells were labeled with the £uorescent cytosolic probe calcein AM
(10 WM, ex/em 492/516 nm). Envelope-expressing cells (5U104) were
added to the respective adherent fusion partners on the 12-well plates
in 1 ml of medium. The two cell populations were incubated for 3 h at
various temperatures. To determine the role of Ca2 ions, the e¡ector
and target cells were washed several times with the Dulbecco’s phos-
phate-bu¡ered saline (PBS) (without Ca2/Mg2) to remove calcium
and then resuspended either in Earle’s balanced salt solution without
calcium (EBSS3Ca2) or EBSS supplemented with 1.8 mM calcium
(EBSS+Ca2). Target and e¡ector cells were co-cultured at 37‡C as
described above in EBSS3Ca2 or EBSS+Ca2. In experiments to
study the e¡ect of cytoskeletal elements, incubations were done in
the presence or absence of 0.5 Wg/ml cytochalasin B [10]. At the end
of incubations, the phase and £uorescence images were collected. Im-
age analysis for dye mixing was performed with Metamorph image
analysis software as described [6]. Bright ¢eld images were used to
distinguish false positives where labeled cells were lying over one
another but had not actually fused. Percent fusion is calculated as:
% fusion = 100U(number of nuclei positive for both dyes)/(total num-
ber of nuclei).
3. Results
3.1. Temperature dependence of cell^cell fusion induced by the
HIV envelope glycoprotein
Previous studies have shown that HIV-1 envelope glycopro-
tein-mediated fusion with CD4 cells is a temperature-depen-
dent process and fusion occurs only at v 31‡C [11]. To deter-
mine whether HIV-2-mediated fusion follows a similar
temperature dependence, we studied fusion of two CD4-de-
pendent X4-utilizing HIV-2 envelope glycoproteins (HIV-
2ROD and HIV-2SBL=ISY). Cells expressing the HIV-2ST enve-
lope glycoprotein which do not fuse with HeLa-CD4 cells [12]
were used as controls. Fig. 1A shows images of calcein-loaded
envelope-expressing cells following incubation with CMTMR-
labeled HeLa-CD4 cells for 3 h at 25‡C. Dye redistribution as
a result of fusion occurred with HIV-2ROD- and HIV-2SBL=ISY-
expressing cells, but not with the cells expressing the HIV-1Lai
envelope glycoprotein. Fig. 1B shows data collected from
many such images as a function of temperature. Cells express-
ing HIV-2SBL=ISY and HIV-2ROD glycoprotein fused with
HeLa-CD4 target cells at the lower temperatures (25‡C and
28‡C) whereas no fusion with HIV-1BH8-expressing cells was
observed. There was no fusion with the HIV-1 envelope gly-
coprotein-expressing cells even after incubations with target
cells for 24 h at 25‡C. No fusion was observed when cells
expressing HIV-2ST strain were incubated with HeLa-CD4
cells at all the temperatures studied, indicating that the dye
transfer resulted from speci¢c fusion.
3.2. HIV-2 envelope glycoprotein-mediated fusion does not
require Ca2+
Previous studies have shown that membrane fusion between
HIV-1 gp120^gp41-expressing and CD4 cells requires calci-
um ions in the incubation medium [13]. To examine whether
calcium ions are also required for HIV-2 envelope glycopro-
tein-induced fusion with CD4 cells, we co-cultured HeLa-
CD4 and gp120^gp41 (from HIV-1 or HIV-2 envelope)-ex-
pressing cells at 37‡C in the presence of incubation medium
devoid of calcium ions (EBSS3Ca2). Fusion was monitored
by observing formation of syncytia as well as by transfer or
£uorescent probes between fusing cells. Cells expressing HIV-
1Lai and HIV-2 envelope (HIV-2ROD and HIV-2SBL=ISY) fused
with HeLa-CD4 cells as judged by the formation of syncytia
in the presence of EBSS+Ca2, consistent with previous ob-
servations (Fig. 2A). On the other hand, when incubations
were performed in EBSS3Ca2, fusion was only observed
with HIV-2 but not HIV-1 envelope-expressing cells (Fig.
2B). However, a reduction in the formation of syncytia was
observed in EBSS3Ca2 as compared to the incubations done
in EBSS+Ca2 (Fig. 2A). Using the dye redistribution assay,
we show that cells expressing HIV-2 envelope glycoprotein
fused with HeLa-CD4 cells when incubated in EBSS3Ca2.
Incubation of HeLa-CD4 and HIV-1 envelope-expressing cells
in EBSS3Ca2, however, did not show any dye transfer con-
sistent with previously reported observations [13]. We did not
observe any dye transfer when HIV-2 envelope glycoprotein-
expressing cells were incubated with NIH 3T3-CD4 cells
(CXCR4 negative) as targets (Fig. 2B), con¢rming speci¢city
of dye transfer as a result of fusion. Although calcium ions
are not required for HIV-2 fusion, fusion was enhanced in the
presence of Ca2 ion in the culture medium (Fig. 2A,B).
3.3. E¡ects of cytoskeletal dynamics on HIV-2 envelope
glycoprotein-mediated fusion
It has been shown previously that treatment of target cells
with cytochalasin B [11] and D [14] blocks HIV-1 envelope
glycoprotein-mediated fusion, presumably by inhibiting actin
polymerization. Our observation that HIV-2 envelope glyco-
protein-mediated cell^cell fusion occurs at lower temperatures
(Fig. 1) and does not require calcium ions (Fig. 2) suggests
that the cellular dynamics involved in HIV-2 envelope glyco-
protein-mediated fusion might be di¡erent than that for HIV-
1. We therefore tested the e¡ect of cytochalasin B, which
a¡ects cytoskeletal dynamics on HIV-2 fusion. Fig. 3 shows
that syncytia formation mediated by the HIV-1 envelope gly-
coprotein was completely inhibited in the presence of 0.5 WM
cytochalasin B, in accordance with previous studies [11]. How-
ever, there was no inhibition of HIV-2-mediated fusion and
syncytia formation under identical conditions. These observa-
tions were con¢rmed using the dye redistribution assay de-
scribed in Fig. 1 (data not shown). Therefore, in contrast to
HIV-1, cytoskeletal dynamics do not appear to play an im-
portant role in HIV-2 envelope glycoprotein-mediated fusion.
4. Discussion
HIV-1 and HIV-2 infect susceptible cells by fusion of the
viral membrane with the cell plasma membrane. This process
is mediated by the interactions of the envelope glycoproteins
with CD4 and coreceptors on the host cell surface [9], that
lead to the conformational changes enabling gp41 to form a
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Fig. 1. Temperature dependence of HIV-1 and HIV-2 envelope glycoprotein-mediated fusion. Target cells were plated on 12-well tissue culture
plates at 105 cells per well, and labeled with the cytoplasmic dye CMTMR (10 WM, ex/em 550/565 nm). HeLa cells were infected with the vac-
cinia recombinants to express viral proteins on the cell surface and labeled with the £uorescent cytosolic probe calcein AM (10 WM, ex/em 492/
516 nm) and resuspended in D10. 5U104 envelope-expressing cells were added to the wells containing HeLa-CD4 cells and incubated for 3 h
at various temperatures in a humidi¢ed incubator and 5% CO2. At the end of incubations, images were collected using a 20U objective and fu-
sion was scored using the assay described in the text. A: A micrograph showing fusion at 25‡C. Red^green overlays were done using Meta-
morph software (Universal Imaging Inc.). Positive fusion is indicated by s . B: Extent of fusion at various temperatures.
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viral ‘hairpin’ [15,16] followed by assembly of the gp41 hair-
pins into a fusion pore [17]. Since it has been shown that
various animal enveloped viruses can fuse with targets which
do not produce energy (e.g. liposomes, red blood cell ghosts,
plasma membrane vesicles) [18,19], it appears that the viral
envelope glycoprotein-mediated fusion process per se does not
require input of metabolic energy from the target cell [20]. For
those viral envelope glycoproteins whose fusogenic structures
comprise coiled coils [21], the energy required to bend lipids
into shapes required for fusion is hypothesized to be derived
from the formation of these coiled coils [22].
However, HIV-1 envelope glycoprotein-mediated fusion
seems to bear the hallmarks of a requirement for target cell
energy sources. One of those hallmarks is temperature depen-
dence: in mammalian cells most cellular metabolic processes
occur atV37‡C. Moreover, the requirement for Ca2 and the
inhibition of HIV-1 fusion by cytochalasin are most likely due
to cellular dynamics which involve assembly and disassembly
Fig. 3. The dependence of HIV-1 and HIV-2 envelope glycoprotein-mediated fusion on actin polymerization. HeLa-CD4 and HIV envelope-ex-
pressing cells were co-cultured (as described in the legend to Fig. 1) in the presence or absence of 0.5 Wg/ml cytochalasin B for 3 h at 37‡C. At
the end of incubations, images were collected using a 20U objective. To distinguish small multinucleated cells occasionally found in cell cul-
tures in the absence of fusion, formation of syncytia was con¢rmed by monitoring presence of CMTMR and calcein in the same population of
cells (not shown).
Fig. 2. Ca2 dependence of HIV-1 and HIV-2 envelope glycoprotein-induced fusion. HeLa-CD4 cells plated on 12-well tissue culture plates
were labeled with CMTMR and envelope-expressing cells were labeled with calcein described in the legend to Fig. 1. Cells were washed several
times with Dulbecco’s PBS (without Ca2/Mg2), and were either resuspended in EBSS+Ca2 or EBSS3Ca2. Target and e¡ector cells were
co-cultured for 3 h at 37‡C (see legend to Fig. 1). At the end of incubations, images were collected using a 20U objective and fusion was
scored following procedures described in the text. To distinguish small multinucleated cells occasionally found in cell cultures in the absence of
fusion, formation of syncytia was con¢rmed by monitoring presence of CMTMR and calcein in the same population of cells (not shown).
A: A micrograph showing fusion of HIV envelope-expressing cells with HeLa-CD4 cells in the absence or presence of Ca2 ions. B: Extent of
fusion in absence or presence of Ca2 ions. NIH 3T3-CD4 cells were used as negative controls in this experiment.
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of the actin network. It is unlikely that this energy is required
to produce the conformational changes in HIV-1 gp120^gp41
since sCD4 induced shedding of gp120, which is an extreme
manifestation of such conformational changes, occurs readily
at 22‡C with HIV-1 [23]. Moreover, in a study of varying
temperature dependence of post-attachment neutralization of
HIV-1 by monoclonal antibodies to gp120, changes in epitope
exposure were demonstrated at temperatures of V26‡C [24].
Why then are these energetic factors important for HIV-1
envelope glycoprotein-mediated fusion? For HIV-1, it appears
that massive conformational changes leading to aggregates of
gp120^gp41-CD4 and coreceptor are involved in the initial
stages of fusion [9,25]. It has recently been shown that addi-
tion of gp120 to activated peripheral blood mononuclear cells
caused polarized co-capping of CD4 and CXCR4 with sub-
sequent pseudopod formation [14]. Pretreatment of the cells
with cytochalasin D blocked these membrane changes com-
pletely. Based on those observations, we hypothesize that con-
¢nement of gp120^gp41-CD4^coreceptor complexes in a lim-
ited area on the cell surface (co-capping) is essential to
produce a local high concentration of transient gp41 pre-hair-
pins which then can self-assemble to form a fusion pore. If, in
the case of HIV-1, the gp41 pre-hairpin formation is spread
out over the cell surface, these molecules may inactivate be-
fore they self-assemble. This would occur when cellular dy-
namic processes are impaired at lower temperatures, absence
of Ca2 or inhibition of actin polymerization. We surmise that
in the case of HIV-2, the gp41 pre-hairpin is more stable and
does not require the highly localized assembly of these struc-
tures. Therefore, the energy-dependent localization of the
complexes (co-capping) is not required in the case of HIV-2
and fusion can proceed at lower temperatures, in the absence
of Ca2, and in the presence of cytochalasin B. The role of
glycosphingolipids in the HIV-1 entry process [6,26,27] may
also be related to the requirement for generation of gp41 pre-
hairpins in localized areas on the cell surface. Further experi-
ments are required to test this hypothesis.
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